Atria Wealth Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$348K	Buy	13,935 +1,453	+12%	+$31.8K	0.01%	1083
2025 Q1	$259K	Sell	12,482 -7,310	-37%	-$184K	﹤0.01%	1563
2024 Q4	$466K	Buy	19,792 +10,841	+121%	+$267K	0.01%	1310
2024 Q3	$229K	Sell	8,951 -2,307	-20%	-$58.7K	﹤0.01%	1690
2024 Q2	$264K	Sell	11,258 -1,562	-12%	-$39.4K	﹤0.01%	1591
2024 Q1	$369K	Sell	12,820 -10,520	-45%	-$316K	﹤0.01%	1413
2023 Q4	$766K	Sell	23,340 -431	-2%	-$11.7K	0.01%	994
2023 Q3	$662K	Sell	23,771 -7,019	-23%	-$229K	0.01%	1005
2023 Q2	$1.05M	Buy	30,790 +5,947	+24%	+$187K	0.01%	814
2023 Q1	$747K	Sell	24,843 -5,536	-18%	-$172K	0.01%	935
2022 Q4	$858K	Sell	30,379 -1,036	-3%	-$32.9K	0.01%	819
2022 Q3	$1.03M	Buy	31,415 +6,285	+25%	+$231K	0.02%	701
2022 Q2	$791K	Buy	25,130 +7,323	+41%	+$256K	0.01%	802
2022 Q1	$818K	Buy	+17,807	New	+$849K	0.01%	814